Cargando…
Placebo Trends across the Border: US versus Canada
BACKGROUND: Physicians around the world report to using placebos in a variety of situations and with varying degrees of frequency. Inconsistent methodologies, however, complicate interpretation and prevent direct comparisons across studies. While US- and Canada-based physicians share similar profess...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659632/ https://www.ncbi.nlm.nih.gov/pubmed/26606749 http://dx.doi.org/10.1371/journal.pone.0142804 |
_version_ | 1782402656368590848 |
---|---|
author | Harris, Cory S. Campbell, Natasha K. J. Raz, Amir |
author_facet | Harris, Cory S. Campbell, Natasha K. J. Raz, Amir |
author_sort | Harris, Cory S. |
collection | PubMed |
description | BACKGROUND: Physicians around the world report to using placebos in a variety of situations and with varying degrees of frequency. Inconsistent methodologies, however, complicate interpretation and prevent direct comparisons across studies. While US- and Canada-based physicians share similar professional standards, Canada harbours a less-litigious universal healthcare model with no formal placebo-related policy—factors that may impact how physicians view and use placebos. METHODS: To compare American and Canadian data, we circulated an online survey to academic physicians practicing in Canada, collected anonymous responses, and extracted those of internists and rheumatologists for comparison to US data obtained through parallel methodologies. RESULTS: Whereas our data show overall concordance across the border—from definitions to ethical limitations and therapeutic potential—differences between American- and Canadian-based placebo practices merit acknowledgement. For example, compared to 45%-80% among US-based respondents, only 23±7% of Canada-based respondents reported using placebos in clinical practice. However, 79±7% of Canada-respondents—a figure comparable to US data—professed to prescribing at least one form of treatment without proven or expected efficacy. Placebo interventions including unwarranted vitamins and herbal supplements (impure placebos) as well as sugar pills and saline injections (pure placebos) appear more common in Canada, where more doctors described placebos as “placebos” (rather than “medications”) and used them as a “diagnostic” tool (rather than a means of placating patient demands for treatment). INTERPRETATION: Cross-border variation in the use of clinical placebos appears minor despite substantial differences in health care delivery system, malpractice climate, and placebo-related policy. The prevalence of impure placebos in both Canadian and US clinics raises ethical and practical questions currently unaddressed by policy and warranting investigation. |
format | Online Article Text |
id | pubmed-4659632 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-46596322015-12-02 Placebo Trends across the Border: US versus Canada Harris, Cory S. Campbell, Natasha K. J. Raz, Amir PLoS One Research Article BACKGROUND: Physicians around the world report to using placebos in a variety of situations and with varying degrees of frequency. Inconsistent methodologies, however, complicate interpretation and prevent direct comparisons across studies. While US- and Canada-based physicians share similar professional standards, Canada harbours a less-litigious universal healthcare model with no formal placebo-related policy—factors that may impact how physicians view and use placebos. METHODS: To compare American and Canadian data, we circulated an online survey to academic physicians practicing in Canada, collected anonymous responses, and extracted those of internists and rheumatologists for comparison to US data obtained through parallel methodologies. RESULTS: Whereas our data show overall concordance across the border—from definitions to ethical limitations and therapeutic potential—differences between American- and Canadian-based placebo practices merit acknowledgement. For example, compared to 45%-80% among US-based respondents, only 23±7% of Canada-based respondents reported using placebos in clinical practice. However, 79±7% of Canada-respondents—a figure comparable to US data—professed to prescribing at least one form of treatment without proven or expected efficacy. Placebo interventions including unwarranted vitamins and herbal supplements (impure placebos) as well as sugar pills and saline injections (pure placebos) appear more common in Canada, where more doctors described placebos as “placebos” (rather than “medications”) and used them as a “diagnostic” tool (rather than a means of placating patient demands for treatment). INTERPRETATION: Cross-border variation in the use of clinical placebos appears minor despite substantial differences in health care delivery system, malpractice climate, and placebo-related policy. The prevalence of impure placebos in both Canadian and US clinics raises ethical and practical questions currently unaddressed by policy and warranting investigation. Public Library of Science 2015-11-25 /pmc/articles/PMC4659632/ /pubmed/26606749 http://dx.doi.org/10.1371/journal.pone.0142804 Text en © 2015 Harris et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Harris, Cory S. Campbell, Natasha K. J. Raz, Amir Placebo Trends across the Border: US versus Canada |
title | Placebo Trends across the Border: US versus Canada |
title_full | Placebo Trends across the Border: US versus Canada |
title_fullStr | Placebo Trends across the Border: US versus Canada |
title_full_unstemmed | Placebo Trends across the Border: US versus Canada |
title_short | Placebo Trends across the Border: US versus Canada |
title_sort | placebo trends across the border: us versus canada |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4659632/ https://www.ncbi.nlm.nih.gov/pubmed/26606749 http://dx.doi.org/10.1371/journal.pone.0142804 |
work_keys_str_mv | AT harriscorys placebotrendsacrosstheborderusversuscanada AT campbellnatashakj placebotrendsacrosstheborderusversuscanada AT razamir placebotrendsacrosstheborderusversuscanada |